ArticlePediatric blood & cancer2011

Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program.

E Anders Kolb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.